Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Inside the Bloodbath at the NIH. Sources say that a climate of fear has spread throughout the agency as the Trump administration takes a hatchet to its core functions.

    5. Juni 2025

    Al Qaeda Refuses to Die – The Cipher Brief

    4. Juni 2025

    The Pros and Cons of Bluetooth Speakers

    4. Juni 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Health»Neurode wants to treat and track ADHD symptoms through a wearable headband
    Health

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    HealthradarBy Healthradar1. Juni 2025Keine Kommentare4 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Neurode wants to treat and track ADHD symptoms through a wearable headband
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Attention deficit hyperactivity disorder (ADHD) affects more than 366 million adults globally, according to a 2020 study, but beyond medicating with stimulants like Adderall and Ritalin, there are few alternatives for people who suffer from the disorder. Therapy, education, and lifestyle changes are usually also advised, but those avenues can prove difficult as well.

    Sydney-based Neurode has come up with a novel way to offer some relief to people with ADHD: a wearable headband that can track and treat ADHD symptoms. And you only have to wear it for 20 minutes a day.

    The headband uses light electrical stimulation in the prefrontal cortex — some people feel a tingling sensation while others don’t feel anything — to balance the brain. The company said this type of stimulation helps treat ADHD symptoms like lack of focus and can compound over time as people continue to use the product. And for tracking, the device uses light to monitor and record changes in brain activity.

    Neurode co-founder Nathalie Gouailhardou is a neuroscientist and was diagnosed with ADHD when she was five. She told TechCrunch that stimulant treatment never really worked for her because the drug’s side effects, like insomnia and anxiety, outweighed the potential benefits.

    She came up with the idea for Neurode while working with non-invasive brain imaging machines known as fNIRS (functional near-infrared spectroscopy) at medical research lab Bionics Institute. Gouailhardou said it was rare for even neuroscientists to get access to such machines, and she wondered if there was a way to get the tech out of the lab and use it to treat conditions like ADHD.

    To figure out if that was even possible, she turned to Damian Sofrevski, a friend and now co-founder who she used to tinker on medical devices with.

    “I called up Damian and said, ‘Why is it so big and expensive?” Gouailhardou recalled. “He looked into it for a little while and he couldn’t come up with a good enough reason. That insight formed the basis of our company and tech innovation. We went on to take the big expensive brain imaging device and reduce its cost and size by 100x.”

    The company was founded in 2021 and filed patents for its device that year. Neurode has since raised $3.5 million in pre-seed funding, led by Khosla Ventures, with participation from PsyMed Ventures, to fund its clinical trials.

    The device is currently available through a private beta. Gouailhardou said the goal is to have the gadget be an FDA-approved medical device, but she doesn’t have a timeline for that application process yet.

    Alex Morgan, a partner at Khosla Ventures, said the firm was interested in the company because of the team and their progress, and also because the ADHD treatment space was ripe for innovation. He told TechCrunch that stimulant drugs are great if they help people, but the industry could use a treatment younger than World War II — and one that isn’t banned in countries like Japan due to its side effects.

    Morgan added that Neurode’s medical device approach also stood out. “They are taking some known things and are making them small and usable in the home,” Morgan said. “A lot of products and technology aren’t great if people can’t get access to them and use them. For all the science, if we don’t make it so people can use it, it doesn’t really help anyone.”

    There have been other venture-backed startups looking to improve ADHD treatment. Some like HelloSelf and Inflow connect people to licensed therapists. Others like Numo and Sidekick are meant to help users focus on completing tasks. Cerebral is another startup in the space, but it came under fire in 2022 for over-prescribing ADHD medication.

    Neurode’s approach is a bit different and it has the potential to expand beyond just ADHD, too. Gouailhardou said Neurode’s wearable could be used to track other conditions like age-related cognitive decline and depression, and the company may explore those areas in the future.

    “I feel really grateful to be building in a space that benefits me and also others,” Gouailhardou said. “It’s lucky. Obviously, having ADHD has all these downsides, but being able to be empowered to solve my own problem and see it helps other people is really rewarding.”

    Editor’s note: This story was corrected on September 10, 2024, to clarify that 366 million adults worldwide have been diagnosed with ADHD.



    Source link

    adhd headband HealthTech medical device Neurode Startups symptoms track treat venture capital Wearable
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleIllinois House passes bill allowing terminally ill people to end their lives with physician’s help
    Next Article Whoop wants everyone to give a whoop about the new Whoop 5.0
    ekass777x
    Healthradar
    • Website

    Related Posts

    Health

    Inside the Bloodbath at the NIH. Sources say that a climate of fear has spread throughout the agency as the Trump administration takes a hatchet to its core functions.

    5. Juni 2025
    Health

    3-Year Exercise Program Improves Colon Cancer Survival Rates

    4. Juni 2025
    Health

    watchOS 12: 3 things I expect to see Tim Cook announce at this year’s WWDC

    3. Juni 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Which Online Poker Game Should You Play?

    31. Mai 20259 Views

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20254 Views

    One In Four European Firms Ban Grok AI Chatbot Over Security Concerns

    1. Juni 20252 Views

    Bayer Launches Centafore Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development

    1. Juni 20252 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Which Online Poker Game Should You Play?

    31. Mai 20259 Views

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20254 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.